← Leaderboards
Maria Amparo Ruiz Garzon
New York University School Of Medicine
$2,879,591
Attributed
$4,304,427
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,304,427 · 4
By mechanism
R01$3,484,047 · 2
R21$820,380 · 2
Top collaborators
- Jose Maria Raya Garcia Del Olmo4 shared
- Thorsten Kirsch3 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Jose Maria Raya Garcia Del Olmo$3,393,166
- Guillaume Madelin$7,348,541
- Jenny T. Bencardino$205,095
Others in their field
Other Emerging Leaders on “Response To Injury”
- Ashlee Fitch · Steelworker Charitable/Educational Org$14,396,687
- Manish Ishwar Shah · Baylor College Of Medicine$13,280,421
- David Turcotte · University Of Massachusetts Lowell$9,723,079
- Romergryko Geocadin · University Of Michigan At Ann Arbor$8,619,592
- Nicholas David Thomson · Virginia Commonwealth University$7,188,375
- James Jeffrey Sahn · 4e Therapeutics Inc.$7,064,669
Research focus
Response To InjuryTissuesAnterior Cruciate Ligament RuptureCellsMolecularImageInjuryMagnetic Resonance ImagingPlayJointsSynovial FluidInflammationValidationBiologicalJoint DestructionPreventResponseEventArticular CartilageFollow-UpCartilageGenesAnimalsImaging Approach
Grant awards (9)
Imaging and therapeutic targeting of tissue crosstalk in the injured knee$711,921
R01 · FY2025 · AR · contact PI
Genomic and Imaging Markers to Understand and Predict Progression of Joint Damage After Injury$576,942
R01 · FY2025 · AR
Imaging and therapeutic targeting of tissue crosstalk in the injured knee$742,834
R01 · FY2024 · AR · contact PI
Genomic and Imaging Markers to Understand and Predict Progression of Joint Damage After Injury$706,587
R01 · FY2024 · AR
Genomic and Imaging Markers to Understand and Predict Progression of Joint Damage After Injury$745,763
R01 · FY2023 · AR
Imaging Low Grade Inflammation with CD44 Mimetic Peptides$223,740
R21 · FY2020 · AR
A Novel Contrast Agent for Post-Traumatic Osteoarthritis Imaging$186,450
R21 · FY2020 · AR · contact PI
A Novel Contrast Agent for Post-Traumatic Osteoarthritis Imaging$223,740
R21 · FY2019 · AR · contact PI
Imaging Low Grade Inflammation with CD44 Mimetic Peptides$186,450
R21 · FY2019 · AR